Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation
1 September 2019 (09:30 - 09:45)
Organised by:
Abstract
About the speaker
University Medical Centre of Gottingen (UMG), Goettingen (Germany)
5 More presentations in this session
Mrs M. Jacobs (Groningen, NL)
Mr L. Iden (Bad Segeberg, DE)
Doctor J. Carmo (Carnaxide, PT)
Doctor M. Jan (Ljubljana, SI)
Doctor A. Verma (Montreal, CA)
Access the full session
The Event
ESC Congress 2019
1 September 2019
09:30 CET
You may be interested in
Congress Session
Congress Session
Congress Session
